Bio Spectrum - February 2024Add to Favorites

Bio Spectrum - February 2024Add to Favorites

Keine Grenzen mehr mit Magzter GOLD

Lesen Sie Bio Spectrum zusammen mit 9,000+ anderen Zeitschriften und Zeitungen mit nur einem Abonnement   Katalog ansehen

1 Monat $9.99

1 Jahr$99.99 $49.99

$4/monat

Speichern 50%
Hurry, Offer Ends in 3 Days
(OR)

Nur abonnieren Bio Spectrum

1 Jahr$11.88 $7.99

Diwali Sale - Speichern 33%
Hurry! Sale ends on November 4, 2024

Diese Ausgabe kaufen $0.99

Geschenk Bio Spectrum

7-Day No Questions Asked Refund7-Day No Questions
Asked Refund Policy

 ⓘ

Digital Subscription.Instant Access.

Digitales Abonnement
Sofortiger Zugriff

Verified Secure Payment

Verifiziert sicher
Zahlung

In dieser Angelegenheit

Can organoids usher in cheap & effective cancer therapeutics?
Dozens of science and technology development payloads returned to Earth from the International Space Station (ISS) as SpaceX’s 29th Commercial Resupply Services
(CRS) mission, contracted by NASA, successfully concluded on December 22, 2023. More than 30 payloads sponsored by the ISS National Laboratory returned on this mission, many of which were life science investigations aimed at benefiting
humanity by improving care for patients on Earth. One among the payloads was an investigation from the University of California, San Diego (UCSD), which studied microgravity’s effects on stem-cell derived brain organoids (lab grown replicas of human organs). While this might seem like science fiction, the story of organoids dates back to 1907. Fast forward to today, these tiny replicas of human organs are experiencing a dramatic surge in popularity, transforming the face of drug discovery research. Dubbed as powerful ‘human modelling systems’, organoids are paving the way for personalised medicines and shaking up the global drug development scene.
India, too, is joining the bandwagon. Let’s explore the world of organoids and how it is pushing the boundaries of personalised medicine research and precision oncology.

Bio Spectrum Magazine Description:

VerlagMM Activ Sci-Tech Communication

KategorieBusiness

SpracheEnglish

HäufigkeitMonthly

India's leading publication that covers the business of bio-technology. With comprehensive analyses of policy issues, products and services across the bio-pharma, bio-informatics, bio-infrastructure and bio-agriculture segments, it is the industry's most authoritative source of information.

  • cancel anytimeJederzeit kündigen [ Keine Verpflichtungen ]
  • digital onlyNur digital
MAGZTER IN DER PRESSE:Alle anzeigen